Evidence map›Paper›PMID 37655851›Full record

ArticleJournal of cell science2023

Mitochondrial phospholipid metabolism in health and disease.

Alaumy Joshi, Travis H Richard, Vishal M Gohil

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alaumy JoshiDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.ORCID 0000-0002-4637-5639
Travis H RichardDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.
Vishal M GohilDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.ORCID 0000-0002-9920-2563
Texas A&M University · US

Funding

Molecular Mechanisms of Copper Delivery to Mitochondrial Cytochrome c OxidaseR01GM111672 · NIGMS · TEXAS A&M AGRILIFE RESEARCH · PI GOHIL, VISHAL MAHENDRASINGH · 2014 to 2022
$2.8M
Mechanisms of elesclomol-mediated copper delivery to cuproenzymes in cellsR01GM143630 · NIGMS · TEXAS A&M AGRILIFE RESEARCH · PI GOHIL, VISHAL MAHENDRASINGH · 2021 to 2023
$979k
NIGMS NIH HHS R01 GM111672NIGMS NIH HHS R01 GM143630
6 · The paper itself

Abstract

Studies of rare human genetic disorders of mitochondrial phospholipid metabolism have highlighted the crucial role that membrane phospholipids play in mitochondrial bioenergetics and human health. The phospholipid composition of mitochondrial membranes is highly conserved from yeast to humans, with each class of phospholipid performing a specific function in the assembly and activity of various mitochondrial membrane proteins, including the oxidative phosphorylation complexes. Recent studies have uncovered novel roles of cardiolipin and phosphatidylethanolamine, two crucial mitochondrial phospholipids, in organismal physiology. Studies on inter-organellar and intramitochondrial phospholipid transport have significantly advanced our understanding of the mechanisms that maintain mitochondrial phospholipid homeostasis. Here, we discuss these recent advances in the function and transport of mitochondrial phospholipids while describing their biochemical and biophysical properties and biosynthetic pathways. Additionally, we highlight the roles of mitochondrial phospholipids in human health by describing the various genetic diseases caused by disruptions in their biosynthesis and discuss advances in therapeutic strategies for Barth syndrome, the best-studied disorder of mitochondrial phospholipid metabolism.

Indexed as

Lipid MetabolismMitochondriaBiological TransportHumansMitochondrial MembranesPhospholipidsRare DiseasesPhospholipidsBarth syndromeCardiolipinMembranesMitochondriaPhosphatidylethanolaminePhospholipids

Identifiers

PMID37655851
PMCPMC10482392
OpenAlexW4386347722

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.